Ses Hakkında Öğrenci Zihinsel Modellerinin Belirlenmesi

by Mehmet Altan Kurnaz, Mustafa Kemal Yüzbaşıoğlu
Published 2020-07-01

The Analysis of Secondary School Students’ Transition Situations in Multiple Representations

by Mehmet Altan Kurnaz, Nezihe Gökçen Bayri
Published 2018-03-01

Comparative Analysis of the Science Teaching Curricula in Turkey

by Ömer Volkan Yaz, Mehmet Altan Kurnaz
Published 2020-01-01

Mental Models of School for Preschool Children

by A. Oguzhan Kildan, Mehmet Altan Kurnaz*, Berat Ahi
Published 2013-04-01

Effects Of A Regular Exercise Program On Life Quality Of Patients With Type 2 Diabetes Mellitus

by Şensu DİNÇER, Murat MENGİ, Sertaç YAKAL, Sevtun Algan SOFYALI, Mehmet ALTAN, Kubilay KARŞIDAĞ, Gökhan METİN
Published 2016-09-01

658 Toxicities of single agent and combination immune checkpoint inhibitors in patients with pre-existing autoimmune diseases

by Jeffrey Weber, Michelle Krogsgaard, Anna Pavlick, Mehmet Altan, Sabina Sandigursky, Safa Houssein, Xerxes Pundole, Elizaveta Efuni, Samuel Cytryn
Published 2020-11-01

Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC)

by Daniel Carvajal-Hausdorf, Mehmet Altan, Vamsidhar Velcheti, Scott N. Gettinger, Roy S. Herbst, David L. Rimm, Kurt A. Schalper
Published 2019-03-01

Clinical characteristics and outcomes of immune checkpoint inhibitor-induced pancreatic injury

by Hamzah Abu-Sbeih, Tenglong Tang, Yang Lu, Selvi Thirumurthi, Mehmet Altan, Amir A. Jazaeri, Ramona Dadu, Emmanuel Coronel, Yinghong Wang
Published 2019-02-01

Effects of Acute Exhaustive Exercise on Oxidant and Antioxidant System Parameters in Rats with Streptozotocin Induced Diabetes Mellitus

by Ahmet Melih Şahin, Osman Fuat Sönmez, Murat Mengi, Mehmet Altan, Muhammet Sait Toprak, Hakan Ekmekçi, Şensu Dinçer, Gökhan Metin, Lütfi Çakar
Published 2020-06-01

Correction to: Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis

by Hamzah Abu-Sbeih, Lauren Nicholas Herrera, Tenglong Tang, Mehmet Altan, Anne-Marie Chaftari, Pablo C. Okhuysen, Robert R. Jenq, Yinghong Wang
Published 2019-12-01

Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis

by Hamzah Abu-Sbeih, Lauren Nicholas Herrera, Tenglong Tang, Mehmet Altan, Anne-Maria P. Chaftari, Pablo C. Okhuysen, Robert R. Jenq, Yinghong Wang
Published 2019-09-01

Correction: MRI of tumor T cell infiltration in response to checkpoint inhibitor therapy

by Mehmet Altan, Fangxin Hong, John V Heymach, Elizabeth Jiménez-Aguilar, Zihan Wei, Andrew J Plodkowski, Peter Sawan, Jia Luo, Hira Rizvi, Brett W Carter
Published 2020-07-01

Outcomes to first-line pembrolizumab in patients with PD-L1-high (≥50%) non–small cell lung cancer and a poor performance status

by Mehmet Altan, Fangxin Hong, John V Heymach, Elizabeth Jiménez-Aguilar, Zihan Wei, Andrew J Plodkowski, Peter Sawan, Jia Luo, Hira Rizvi, Brett W Carter
Published 2020-07-01

Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance

by Vasiliki Pelekanou, Daniel E. Carvajal-Hausdorf, Mehmet Altan, Brad Wasserman, Cristobal Carvajal-Hausdorf, Hallie Wimberly, Jason Brown, Donald Lannin, Lajos Pusztai, David L. Rimm
Published 2017-08-01

Erratum to: Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance

by Vasiliki Pelekanou, Daniel E. Carvajal-Hausdorf, Mehmet Altan, Brad Wasserman, Cristobal Carvajal-Hausdorf, Hallie Wimberly, Jason Brown, Donald Lannin, Lajos Pusztai, David L. Rimm
Published 2017-09-01

Early introduction of selective immunosuppressive therapy associated with favorable clinical outcomes in patients with immune checkpoint inhibitor–induced colitis

by Hamzah Abu-Sbeih, Faisal S. Ali, Xuemei Wang, Niharika Mallepally, Ellie Chen, Mehmet Altan, Robert S. Bresalier, Aline Charabaty, Ramona Dadu, Amir Jazaeri, Bret Lashner, Yinghong Wang
Published 2019-04-01

283 Safety and efficacy signals in the complete phase I study of live biotherapeutic MRx0518 in combination with pembrolizumab in patients refractory to immune checkpoint inhibitor...

by Alexander Stevenson, Jianjun Gao, Pavlos Msaouel, Nizar Tannir, Mehmet Altan, Shi-Ming Tu, Michael Chisamore, Matthew Campbell, George Blumenschein, Xiuning Le, Frank Mott, Amishi Shah, Jordi Rodon, Imke Mulder
Published 2020-11-01

Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial

by Hari Menon, Dawei Chen, Vivek Verma, Mehmet Altan, John V Heymach, Quynh-Nhu Nguyen, Rejani Varghese, Nathan I Comeaux, George Simon, Ferdinandos Skoulidis, Joe Y Chang, Vasiliki Papdimitrakopoulou, Steven H Lin
Published 2020-07-01

Correction: Therapeutic efficacy and safety of a human fusion construct targeting the TWEAK receptor Fn14 and containing a modified granzyme B

by Hari Menon, Dawei Chen, Vivek Verma, Mehmet Altan, John V Heymach, Quynh-Nhu Nguyen, Rejani Varghese, Nathan I Comeaux, George Simon, Ferdinandos Skoulidis, Joe Y Chang, Vasiliki Papdimitrakopoulou, Steven H Lin
Published 2020-07-01

Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory

by Mehmet Altan, Lilibeth Castillo, Bettzy Stephen, Sarina A Piha-Paul, Tito Mendoza, Goldy George, Enedelia Rodriguez, Christine Peterson, Jordi Rodon Ahnert, Timonthy A Yap, Apostolia M Tsimberidou, Daniel D Karp, Abdulrazzak Zarifa, Lacey M McQuinn, Charles Cleeland
Published 2020-07-01